Calendar Sorrento Therapeutics, Inc. Deutsche Boerse AG
Equities
8STN
US83587F2020
Chart calendar Sorrento Therapeutics, Inc.
Upcoming events on Sorrento Therapeutics, Inc.
No events available
Past events on Sorrento Therapeutics, Inc.
08/03/2023 | Q4 2022 Earnings Release (Projected) |
14/12/2022 | Annual General Meeting |
17/11/2022 16:30 | Investor Meeting - Key Opinion Leader |
12/11/2022 | American College of Rheumatology Convergence Conference |
09/11/2022 15:00 | Extraordinary Shareholders Meeting |
14/09/2022 13:00 | Morgan Stanley Global Healthcare Conference |
14/08/2022 | Interim 2022 Earnings Release |
05/05/2022 22:05 | American Society of Interventional Pain Physicians Meeting |
04/05/2022 | Q1 2022 Earnings Release |
27/04/2022 15:00 | B Riley Securities Virtual Neurology & Ophthalmology Conference |
22/04/2022 | Chinese Society of Clinical Oncology Guideline Conference |
06/01/2022 19:50 | Longwood Healthcare Leaders Winter Conference |
04/01/2022 22:00 | H.C. Wainwright BioConnect Virtual Conference |
01/12/2021 20:30 | Evercore ISI HealthCONx Conference |
15/11/2021 20:00 | Annual General Meeting |
29/09/2021 17:35 | Benzinga Healthcare Small Cap Conference - Panel |
29/09/2021 16:30 | Benzinga Healthcare Small Cap Conference |
29/09/2021 14:20 | Cantor Fitzgerald Global Healthcare Conference |
12/09/2021 | H.C. Wainwright Global Investment Conference |
05/08/2021 | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 21,2 17,8 19.22% | 31,4 25,2 24.74% | 40,0 41,3 -3.1% | 52,9 58,1 -8.91% | 62,8 65,9 -4.65% |
EBITDA Million USD | Released Forecast Spread | -117 -105 -10.86% | -180 -187 3.41% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -150 -139 -8.32% | -259 -236 -9.79% | -245 -214 -14.42% | -377 -368 -2.62% | -504 -448 -12.68% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -214 -194 -10.1% | -360 -346 -3.78% | -311 -282 -10.22% | -463 -368 -25.79% | -562 -462 -21.59% |
Net income Million USD | Released Forecast Spread | -204 -183 -11.18% | -292 -235 -24.22% | -298 -282 -5.71% | -428 -367 -16.57% | -573 -419 -36.74% |
EPS USD | Released Forecast Spread | -1,92 -1,73 -10.77% | -2,20 -2,23 1.35% | -1,30 -1,23 -5.69% | -1,45 -1,25 -16% | -1,37 -1,01 -35.64% |
Announcement Date | 15/03/19 | 03/03/20 | 19/02/21 | 11/03/22 | 16/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 13,5 17,0 -20.59% | 12,1 16,9 -28.63% | 13,1 18,3 -28.36% | 18,4 21,1 -12.96% | 11,5 29,4 -61.04% | 17,4 15,5 12.26% | 15,6 18,7 -16.43% | 16,3 20,0 -18.75% |
EBIT Million USD | Released Forecast Spread | -101 -72,1 -39.48% | -90,3 -87,8 -2.76% | -114 -80,8 -41.18% | -107 -78,7 -35.75% | -118 -71,6 -65.23% | -109 -102 -7.83% | -170 -113 -50.29% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -167 -70,1 -138.55% | -120 -85,7 -39.7% | -178 -83,3 -113.89% | -38,9 -76,3 48.98% | -221 -69,1 -219.08% | -91,7 -105 12.41% | -210 -111 -90.04% | |
Net income Million USD | Released Forecast Spread | -167 -70,1 -137.55% | -120 -85,7 -39.73% | -144 -83,3 -73.47% | -40,8 -76,3 46.53% | -219 -69,1 -216.42% | -89,6 -104 13.7% | -224 -69,8 -220.56% | |
EPS USD | Released Forecast Spread | -0,57 -0,24 -137.5% | -0,40 -0,29 -37.93% | -0,47 -0,27 -74.07% | -0,12 -0,22 45.45% | -0,54 -0,20 -170% | -0,20 -0,26 23.08% | -0,49 -0,15 -226.67% | -0,26 -0,16 -62.5% |
Announcement Date | 06/08/21 | 05/11/21 | 11/03/22 | 05/05/22 | 15/08/22 | 08/11/22 | 16/03/23 | 15/05/23 |
Past sector events for Sorrento Therapeutics, Inc.
11/07/2024 21:00 | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
08/07/2024 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
07/07/2024 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
04/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
06/06/2024 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
06/06/2024 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |